Although an association with an increased risk of liver steatosis compared with non‐carriers can be established, recent studies have not been able to replicate the evidence for the impact of MBOAT7 polymorphisms on disease severity in NAFLD.48, 49. The gene discussed is MBOAT7; the disease is metabolic dysfunction-associated steatotic liver disease.